Loading...
Market
Will a major pharmaceutical company announce a clinical trial for Heparin as a treatment for cobra venom by December 31, 2024?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Press releases and official announcements from pharmaceutical companies
Story
Blood Thinner Heparin Shows Promise in Treating Cobra Venom, Study in Science Translational Medicine Finds
Jul 17, 2024, 07:35 PM
A global study suggests that the common blood thinner heparin could be used to treat cobra venom. Researchers have found that heparin, a widely used anticoagulant, shows promise in neutralizing cobra venom, potentially revolutionizing the treatment of cobra bites. This discovery could drastically reduce the severe injuries caused by cobra bites and improve survival rates. The study, published in Science Translational Medicine, highlights a new treatment strategy based on the molecular dissection of spitting cobra venom.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Only Cobra venom • 25%
Cobra and one other type of venom • 25%
Cobra and multiple other types of venom • 25%
Not effective against any venom • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than 10% • 25%
10% to 25% • 25%
25% to 50% • 25%
More than 50% • 25%
1-2 countries • 25%
3-5 countries • 25%
6-10 countries • 25%
More than 10 countries • 25%
Yes • 50%
No • 50%
